Aesthetic Medical International Holdings Group Past Earnings Performance
Past criteria checks 0/6
Aesthetic Medical International Holdings Group has been growing earnings at an average annual rate of 2.8%, while the Healthcare industry saw earnings growing at 7.2% annually. Revenues have been declining at an average rate of 5.8% per year.
Key information
2.8%
Earnings growth rate
11.3%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | -5.8% |
| Return on equity | -496.6% |
| Net Margin | -6.7% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Aesthetic Medical International Holdings Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 727 | -48 | 388 | 0 |
| 31 Mar 24 | 715 | -48 | 392 | 0 |
| 31 Dec 23 | 683 | -37 | 371 | 0 |
| 30 Sep 23 | 665 | -44 | 358 | 0 |
| 30 Jun 23 | 651 | -82 | 359 | 0 |
| 31 Mar 23 | 658 | -73 | 360 | 0 |
| 31 Dec 22 | 670 | -76 | 377 | 0 |
| 30 Sep 22 | 549 | -363 | 466 | 0 |
| 30 Jun 22 | 678 | -198 | 496 | 0 |
| 31 Mar 22 | 671 | -503 | 560 | 0 |
| 31 Dec 21 | 646 | -587 | 612 | 0 |
| 30 Sep 21 | 965 | -358 | 692 | 0 |
| 30 Jun 21 | 1,078 | -360 | 756 | 0 |
| 31 Mar 21 | 946 | -243 | 748 | 0 |
| 31 Dec 20 | 902 | -235 | 741 | 0 |
| 30 Sep 20 | 777 | -216 | 700 | 0 |
| 30 Jun 20 | 734 | -83 | 656 | 0 |
| 31 Mar 20 | 779 | 35 | 634 | 0 |
| 31 Dec 19 | 869 | 136 | 609 | 0 |
| 30 Sep 19 | 844 | -89 | 522 | 0 |
| 30 Jun 19 | 798 | -192 | 470 | 0 |
| 31 Mar 19 | 764 | -242 | 448 | 0 |
| 31 Dec 18 | 761 | -255 | 449 | 0 |
| 31 Dec 17 | 697 | -77 | 393 | 0 |
| 31 Dec 16 | 585 | 50 | 314 | 0 |
Quality Earnings: 3FMA is currently unprofitable.
Growing Profit Margin: 3FMA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 3FMA is unprofitable, but has reduced losses over the past 5 years at a rate of 2.8% per year.
Accelerating Growth: Unable to compare 3FMA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 3FMA is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (40.5%).
Return on Equity
High ROE: 3FMA has a negative Return on Equity (-496.55%), as it is currently unprofitable.